Objective
A new breed of PET-imaging radiopharmaceuticals originating from the proteomic research is about to emerge, addressing major health concerns such as cancer treatment follow-up. Radiopharmaceuticals involve nano-molar quantities of active ingredients, which make the current radio-synthetic methods and device mostly inadequate to produce them. The availability of instruments scaled down to dimensions matching these quantities will be a major breakthrough. The objective of this proposal is to develop the knowl edge and technology required for the design of a radically new range of miniaturized instruments in order to implement multiple step radio-chemistry processes at the micro molar scale. The new platform will include a smart, single use lab-on-chip component , that integrates and combines micro-fluidic functions and specific chemical functions, in which the processes are carried out. Depending on the compound to be produced, the appropriate chip will be inserted into the instrument. This will provide considera ble benefits in terms of compounds quality, exposure of the operators, operation costs, reduction of waste, securing Europe's endangered leadership in this field. This project integrates and translates knowledge and expertise in a number of fields such as biotechnology, pharmacy, synthetic chemistry, radiochemistry, micro-fluidics and micro-fabrication, electronic and electromechanical miniaturisation. The needed leading edge skills will be properly ensured by Trasis who is experienced in such translational developments and in the production of such systems. The complementarities of the partners, their skills and the multidisciplinary approach ensure high chances of success:3 SMEs and 3 research centers, 4 countries, specialized in design and manufacturing o f tracer production instruments, PET radiochemistry, micro-fluidics design and fast micro-prototyping, micro-tech. simulation, micro-parts mass production and gluco-protein chemistry
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences physical sciences classical mechanics fluid mechanics microfluidics
- engineering and technology other engineering and technologies microtechnology lab on a chip
- natural sciences chemical sciences nuclear chemistry radiochemistry
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine pharmacology and pharmacy
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2003-NMP-TI-3-MAIN
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
LIEGE
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.